The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - EpicentRx
Leadership - EpicentRx
Stock and Other Ownership Interests - EpicentRx
Patents, Royalties, Other Intellectual Property - EpicentRx
Phase I pilot study of RRx-001 + nivolumab in patients with traditionally non-checkpoint inhibitor-responsive cancers (PRIMETIME).
 
Corey Carter
No Relationships to Disclose
 
Scott Caroen
Employment - EpicentRx
Stock and Other Ownership Interests - EpicentRx
Patents, Royalties, Other Intellectual Property - Scott Caroen is on patents relating to EpicentRx, Inc., technologies.
 
Bryan Oronsky
Employment - EpicentRx
Leadership - EpicentRx; EpicentRx (I)
Stock and Other Ownership Interests - EpicentRx
Patents, Royalties, Other Intellectual Property - I am listed as a co-inventor of several technologies under EpicentRx. Inc.
 
Mary Flanagan Quinn
Employment - EpicentRx
 
Jeannie Williams
Employment - EpicentRx
 
Christina E. Brzezniak
No Relationships to Disclose